Efficacy and safety of the oral bradykinin B2 receptor antagonist deucrictibant immediate-release capsule (PHVS416) in treatment of hereditary angioedema attacks: results of RAPIDe-1 phase 2 trial

E. Aygoeren-Puersuen,J. Greve,M. Magerl,P. Staubach,R. Crabbe, H. Chen, L. Zhu,J. Knolle, P. Lu, M. Maurer

ALLERGOLOGIE（2023）

Cited 0|Views0
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined